Clinical Trials Directory

Trials / Unknown

UnknownNCT05784818

Up To Me: Erasing the Stigma of Mental Illness on College Campuses

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
201 (estimated)
Sponsor
University of South Florida · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a three-lesson, disclosure-based stigma reduction program meant to reduce barriers to community living and participation for college students with psychiatric disabilities. The goal is to improve community living and participation of individuals with psychiatric disabilities within their postsecondary community using the Honest Open Proud (HOP) program. There are 3 specific objectives of the project:1) evaluate program fidelity, 2) assess program feasibility, and 3) conduct a randomized controlled trial of the HOP program with college students with mental illness to examine its efficacy. Anticipated outcomes include increases in 1) community integration, 2)self-esteem and self-efficacy, 3) empowerment and self-determination, 4) disclosure of mental illness in order to obtain needed support, and 5) care seeking/service engagement for mental illness. Ultimately, we expect to see increased academic persistence and achievement among HOP program completers.

Conditions

Interventions

TypeNameDescription
BEHAVIORALUp To Me Intervention + No BoosterParticipants will complete two-hour sessions once a week over three weeks in which they complete modules in the Up To Me Workbook. These sessions are facilitated by a peer facilitator and a member of the USF Counseling center. Other members in the group sessions are university students who are peers who are also experiencing some form of shame around their mental health challenges.
BEHAVIORALUp To Me Intervention + BoosterIn addition to the Up To Me Intervention, participants also complete a booster/additional session where additional topics of the Up To Me workbook are covered. This additional session occurs four weeks after the completion of the third session.

Timeline

Start date
2022-03-07
Primary completion
2024-03-30
Completion
2024-03-30
First posted
2023-03-27
Last updated
2023-03-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05784818. Inclusion in this directory is not an endorsement.